Jane Street’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.17M | Sell |
140,247
-245,737
| -64% | -$5.46M | ﹤0.01% | 4249 |
|
|
2025
Q4 | $9.99M | Buy |
385,984
+239,315
| +163% | +$5.69M | 0.01% | 2319 |
|
|
2025
Q3 | $3.78M | Sell |
146,669
-14,349
| -9% | -$352K | ﹤0.01% | 3849 |
|
|
2025
Q2 | $3.85M | Sell |
161,018
-183,140
| -53% | -$4.62M | 0.01% | 3368 |
|
|
2025
Q1 | $8.55M | Buy |
344,158
+253,484
| +280% | +$6.07M | 0.02% | 2190 |
|
|
2024
Q4 | $1.71M | Buy |
90,674
+68,517
| +309% | +$1.2M | ﹤0.01% | 4401 |
|
|
2024
Q3 | $333K | Sell |
22,157
-58,773
| -73% | -$1M | ﹤0.01% | 7848 |
|
|
2024
Q2 | $2.32M | Sell |
80,930
-106,601
| -57% | -$3.03M | ﹤0.01% | 4231 |
|
|
2024
Q1 | $5.48M | Buy |
187,531
+177,557
| +1,780% | +$5.45M | 0.01% | 2493 |
|
|
2023
Q4 | $337K | Sell |
9,974
-25,527
| -72% | -$747K | ﹤0.01% | 7438 |
|
|
2023
Q3 | $1.09M | Sell |
35,501
-45,756
| -56% | -$1.65M | ﹤0.01% | 5051 |
|
|
2023
Q2 | $3.26M | Buy |
81,257
+30,608
| +60% | +$1.27M | ﹤0.01% | 3359 |
|
|
2023
Q1 | $2.07M | Buy |
50,649
+2,263
| +5% | +$90K | ﹤0.01% | 3761 |
|
|
2022
Q4 | $1.87M | Buy |
48,386
+37,386
| +340% | +$1.82M | ﹤0.01% | 3967 |
|
|
2022
Q3 | $585K | Sell |
11,000
-21,101
| -66% | -$1.17M | ﹤0.01% | 6395 |
|
|
2022
Q2 | $1.87M | Buy |
32,101
+16,857
| +111% | +$1.1M | ﹤0.01% | 4297 |
|
|
2022
Q1 | $1.16M | Sell |
15,244
-5,167
| -25% | -$344K | ﹤0.01% | 5815 |
|
|
2021
Q4 | $1.23M | Buy |
20,411
+11,416
| +127% | +$629K | ﹤0.01% | 5487 |
|
|
2021
Q3 | $504K | Sell |
8,995
-6,487
| -42% | -$374K | ﹤0.01% | 7265 |
|
|
2021
Q2 | $940K | Buy |
15,482
+12,582
| +434% | +$796K | ﹤0.01% | 5972 |
|
|
2021
Q1 | $203K | Sell |
2,900
-3,427
| -54% | -$245K | ﹤0.01% | 8244 |
|
|
2020
Q4 | $379K | Sell |
6,327
-1,155
| -15% | -$67.6K | ﹤0.01% | 6104 |
|
|
2020
Q3 | $450K | Buy |
7,482
+3,361
| +82% | +$195K | ﹤0.01% | 5316 |
|
|
2020
Q2 | $216K | Buy |
+4,121
| New | +$172K | ﹤0.01% | 6271 |
|
|
2020
Q1 | – | Sell |
-10,860
| Closed | -$492K | – | 5826 |
|
|
2019
Q4 | $492K | Buy |
+10,860
| New | +$461K | ﹤0.01% | 3708 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5594 |
|
|
2019
Q1 | – | Sell |
-18,798
| Closed | -$809K | – | 5478 |
|
|
2018
Q4 | $809K | Buy |
18,798
+5,236
| +39% | +$244K | 0.01% | 2862 |
|
|
2018
Q3 | $667K | Buy |
+13,562
| New | +$586K | ﹤0.01% | 3270 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5503 |
|
|
2018
Q1 | – | Sell |
-10,968
| Closed | -$501K | – | 5295 |
|
|
2017
Q4 | $501K | Buy |
+10,968
| New | +$435K | ﹤0.01% | 3171 |
|
|
2017
Q3 | – | Sell |
-6,064
| Closed | -$289K | – | 4965 |
|
|
2017
Q2 | $289K | Sell |
6,064
-4,804
| -44% | -$223K | ﹤0.01% | 3631 |
|
|
2017
Q1 | $496K | Sell |
10,868
-8,239
| -43% | -$356K | 0.01% | 2889 |
|
|
2016
Q4 | $617K | Sell |
19,107
-697
| -4% | -$23.3K | 0.01% | 2619 |
|
|
2016
Q3 | $678K | Buy |
+19,804
| New | +$776K | 0.01% | 2434 |
|
|
2016
Q2 | – | Sell |
-4,295
| Closed | -$228K | – | 4505 |
|
|
2016
Q1 | $228K | Sell |
4,295
-11,084
| -72% | -$648K | ﹤0.01% | 3549 |
|
|
2015
Q4 | $1.18M | Buy |
+15,379
| New | +$871K | 0.02% | 1577 |
|
|
2015
Q1 | – | Sell |
-4,246
| Closed | -$376K | – | 3430 |
|
|
2014
Q4 | $376K | Sell |
4,246
-3,739
| -47% | -$354K | 0.01% | 1699 |
|
|
2014
Q3 | $774K | Sell |
7,985
-7,907
| -50% | -$769K | 0.02% | 1095 |
|
|
2014
Q2 | $1.46M | Buy |
15,892
+10,742
| +209% | +$818K | 0.03% | 691 |
|
|
2014
Q1 | $360K | Buy |
+5,150
| New | +$350K | 0.01% | 1834 |
|
Other funds holding PCRX
DPCM
VPM
VCM
